COVID-19 These labels are useful during sur-

FDA Updates Extended Use Drugs List to Meet COVID-19 Demands

Protocols ASCs need to put in place to use these medications safely and avoid citations BY SAHELY MUKERJI


n light of the COVID-19 pandemic and the consequent demand for cer- tain medications, the US Food & Drug Administration (FDA) updated its list of extended-use drugs on April 3. The updated list now includes 569 drugs that may be used beyond the manufacturer’s labeled expiration date.

“That listing is limited to certain

drugs but the excess in demand applies to more drugs beyond that listing,” says Sheldon Sones, president of Shel- don S. Sones and Associates of New- ington, Connecticut, and a pharmacy consultant to ASCs. “In effect, there are two kinds of drugs that are in high demand now due to COVID-19: those that are on the FDA listing and those that are not. The ones that are on the list are relatively easy to manage.”

Drugs on the FDA List Most of the drugs on the FDA list- ing are first-line medications used for acute-care treatment in cardiac emer-

gencies, says Robert Taylor, RN, clin- ical director of Constitution Surgery Center East, Waterford, Connecticut, and surveyor for the Accreditation Association for Ambulatory Health Care. “We were ecstatic when FDA updated the list because an ASC has to have those drugs present and we were unable to get them.” Best practice dictates that an ASC labels the drugs that are allowed extended use and documents attempts to find replacement supply, Taylor says. “I print custom-made labels that I dog-ear on the side of the box,” he says. “The labels say ‘extended use per FDA’ with the date on it, usually an additional six months.” The extended date varies and could be up to a year, he says. “The manufacturer has to rec- ommend the efficacy of a certain drug to the FDA. These are all done by lot numbers. For example, Atropine comes in many different sizes and forms, and they all have different efficacy dates.”


veys, as well, Taylor says. “As a sur- veyor, if I walk into an ASC, open up a crash cart and see a box of Atro- pine with an expiry date of March 2020 without a label to identify the extended use, that’d be reason for a citation. The label shows that the ASC is paying attention to the extended use guidelines and doing its due diligence to keep everyone informed.” Aside from labeling, an ASC needs to be cognizant of what is on the FDA list, Taylor says. “ASCs need to check monthly the list of extended use medi- cations on the FDA site and cross-ref- erence it with their own list of extended use drugs,” he says. “They have to have a person dedicated to checking and buying these medications because extended use is a crutch only.” Certain state surveyors ask cen- ters to provide evidence that they are trying to acquire the replacement drug. “So, you cannot be asleep at the wheel,” he says. “You would have to show documented communica- tion with your supplier/wholesaler— like emails or canceled orders—that shows you are trying to acquire the said extended use medication.” Larger centers with multiple ORs

might find it useful to create a list checklist that shows the extended use medications they have in stock and their location, Taylor says. “Ideally, you want those extended use medications to be used first. It’s basically triaging your supplies. The checklist would tell you where your extended use drugs are, so you are not searching for them under every leaf when you need them.” When these extended use drugs

become available in the market, try not to be over-reactive and hoard, Sones recommends. “Stay on top of your supply chain and work with two or more wholesalers. Learn about each supplier’s allocation policies and enlist your projected needs.”

Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46